NCT06822634 Advances in Imaging to Assess Response in Rectal Cancer
| NCT ID | NCT06822634 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NHS Greater Glasgow and Clyde |
| Condition | Colorectal Cancer (CRC) |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-11-11 |
| Primary Completion | 2026-06-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2024-11-11 with a primary completion date of 2026-06-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to determine the feasibility of acquiring serial MRI images for advanced radiotherapy planning in colorectal patients. The main question it aims to answer: Is it feasible to acquire serial MR images for advanced radiotherapy planning for rectal cancer.
Eligibility Criteria
Inclusion Criteria: * Histologically confirmed rectal adenocarcinoma. * T stage 3b or above and/or high risk factors eg. EMVI, nodal disease. * Participant able to give written informed consent. * Male or non-pregnant female ≥18 years of age. * Scheduled to undergo radical radiotherapy. * Patients willing and able to comply with the protocol for the duration of study. Exclusion Criteria: * Contra-indications to MRI, such as claustrophobia, excessive body weight, MRI unsafe implants, ferrous metal in the body, insufficient information on prior surgeries. MRI conditional implants where conditions cannot be met (e.g pacemakers). * Any previous radiotherapy to the pelvis. * Inflammatory bowel disease. * Other severe or uncontrolled systemic disease or evidence of any other significant disorder or lab finding that makes it undesirable for the patient to participate in the study, as determined by the treating clinician. * History of physical or psychiatric disorder that would prevent informed consent and compliance with the protocol. * Patients with de-functioning stoma. * Major surgery within 28 days prior to trial entry.
Contact & Investigator
Ms Lynsey Devlin
PRINCIPAL INVESTIGATOR
NHS Greater Glasgow and Clyde
Frequently Asked Questions
Who can join the NCT06822634 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer (CRC). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06822634 currently recruiting?
Yes, NCT06822634 is actively recruiting participants. Contact the research team at lynsey.devlin@nhs.scot for enrollment information.
Where is the NCT06822634 trial being conducted?
This trial is being conducted at Glasgow, United Kingdom.
Who is sponsoring the NCT06822634 clinical trial?
NCT06822634 is sponsored by NHS Greater Glasgow and Clyde. The principal investigator is Ms Lynsey Devlin at NHS Greater Glasgow and Clyde. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.